Qianqian Tong

This inventor holds 9 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents. Top assignee: Hangzhou Dac Biotech Co., Ltd.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qianqian Tong. Retrieved from https://idiyas.com/inventor/qianqian-tong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 18.5

ph-index = 3

Forward Citations = 20(Granted Patents)

Company Filing History:

9 out of 34

Hangzhou Dac Biotech Co., Ltd.

patents

Years Active: 2020-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478695 - Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof (2025-11-25),

2. 12364767 - Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers (2025-07-22),

3. 12303571 - Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof (2025-05-20),

4. 12285491 - Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers (2025-04-29),

5. 12220464 - Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof (2025-02-11),

6. 11998584 - Conjugate of a tubulysin analog with branched linkers (2024-06-04),

7. 11779663 - Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof (2023-10-10),

8. 11129910 - Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof (2021-09-28),

9. 10836796 - Derivatives of amanita toxins and their conjugation to a cell binding molecule (2020-11-17),

Title: Qianqian Tong: Innovator in Biotech

Introduction

Qianqian Tong is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of conjugation linkers and drug conjugates. With a total of 9 patents, his work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Qianqian Tong's latest patents focus on innovative conjugation linkers and their applications. One of his inventions relates to linkers that contain a group of propiolyl, substituted acryl, or disubstituted propanoyl. These linkers are designed for the conjugation of cytotoxic agents to cell-binding molecules. Another patent introduces novel linkers with a 2,3-disubstituted succinic group or other functional groups for the conjugation of cytotoxic agents. These advancements aim to create homogeneous conjugates that can be used in the treatment of cancers, infections, and autoimmune disorders.

Career Highlights

Throughout his career, Qianqian Tong has worked with notable companies such as Hangzhou Dac Biotech Co., Ltd. and Suzhou M-conji Biotech Co., Ltd. His expertise in biotechnology has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Qianqian has collaborated with talented individuals in his field, including Qingliang Yang and Yuanyuan Huang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Qianqian Tong's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments and drug development.

Profile summary based on public USPTO records.